Discover Weakness Deemed Unwarranted and 4 Stock Analyses to Know Now

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX): Current Price: $8.10

The company’s price target has been increased to $15 by Brean Capital due to positive Ph III Zerenex data. The stock has a Buy rating.

Capture

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!